Supplemental material
Leukemia & Lymphoma
Volume 64, 2023 - Issue 2
Open access
2,115
Views
4
CrossRef citations to date
0
Altmetric
Articles
Healthcare resource use and reimbursement amount by site of care in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell (CAR-T) therapy – a retrospective cohort study using CMS 100% Medicare claims database
Hongbo Yanga Analysis Group, Inc., Boston, MA, USACorrespondence[email protected]
View further author information
, View further author information
Vamsi Bollub Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
, Stephen Limb Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
, Mimi Tesfayeb Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
, Anand A. Dalalb Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
, Angela Laxa Analysis Group, Inc., Boston, MA, USAView further author information
, Sakshi Sethia Analysis Group, Inc., Boston, MA, USAView further author information
& Jing Zhaoa Analysis Group, Inc., Boston, MA, USAView further author information
show all
Pages 339-348
|
Received 09 Jun 2022, Accepted 29 Oct 2022, Published online: 21 Nov 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.